These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25895753)
21. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
22. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Sonnen R; Schmidt WP; Müller-Hermelink HK; Schmitz N Br J Haematol; 2005 May; 129(3):366-72. PubMed ID: 15842660 [TBL] [Abstract][Full Text] [Related]
23. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953 [TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome. Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321 [TBL] [Abstract][Full Text] [Related]
25. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens. Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405 [TBL] [Abstract][Full Text] [Related]
26. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx]. Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649 [TBL] [Abstract][Full Text] [Related]
27. [A survival of 103 cases of T-cell non-Hodgkin lymphoma]. Shi YX; Peng RJ; Lin SX; Wu QL; Lin TY; Sun XF; Huang HQ; Xia ZJ; Li YH; Xu RH; Liu DG; Guan ZZ; Jiang WQ Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):1000-2. PubMed ID: 18478916 [TBL] [Abstract][Full Text] [Related]
28. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255 [TBL] [Abstract][Full Text] [Related]
29. Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype. Heyning FH; Hogendoorn PC; Kramer MH; Holland CT; Dreef E; Jansen PM J Clin Pathol; 2009 Sep; 62(9):820-4. PubMed ID: 19734480 [TBL] [Abstract][Full Text] [Related]
30. [Clinical features and prognosis of nasal type NK/T cell lymphoma]. Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622 [TBL] [Abstract][Full Text] [Related]
31. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas]. Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549 [TBL] [Abstract][Full Text] [Related]
32. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [TBL] [Abstract][Full Text] [Related]
33. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study). Messina C; Ferreri AJ; Govi S; Bruno-Ventre M; Gracia Medina EA; Porter D; Radford J; Heo DS; Park HY; Pro B; Jayamohan J; Visco C; Scarfò L; Zucca E; Gospodarowicz M; Christie D; Br J Haematol; 2014 Mar; 164(6):834-40. PubMed ID: 24383942 [TBL] [Abstract][Full Text] [Related]
34. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367 [TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas. Wu H; Bui MM; Leston DG; Shao H; Sokol L; Sotomayor EM; Zhang L BMC Cancer; 2014 Dec; 14():900. PubMed ID: 25465716 [TBL] [Abstract][Full Text] [Related]
36. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast. Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226 [TBL] [Abstract][Full Text] [Related]